Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q3 2025 vs. Q2 2025
How the institutions holding Aclarion, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 5 | 1 | 8 | +4 |
| Shares | 1.82K | 3 | 22.4K | +20.6K (+1,135.5%) |
| Value | $13.7K | $23 | $168.0K | +$154.3K (+1,131.3%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Aclarion, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 11,575 | $86.8K | 0.00% |
| Captrust Financial Advisors | 10,000 | $75.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 230 | $1.73K | 0.00% |
| Clear Street Group Inc. | 3 | $23 | 0.00% |
| Citigroup Inc | 1 | $8 | 0.00% |
Sold out (1)
Institutions that held Aclarion, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Group AG | 1,729 | $13.0K |
Not filed for Q3 2025 yet (1)
Institutions that held Aclarion, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 3 | $23 |